Colleen M Hayes

age ~52

from Madison, WI

Get Report

Connected to:

Colleen Hayes Phones & Addresses

Madison, WI
Cicero, IL

Work

Company:

Goldberg Segalla LLP
Address:

Specialities

Global Insurance Services

License Records

Colleen J. Hayes

License #:

PIC.014983 - Expired

Issued Date:

Sep 23, 1991

Expiration Date:

Dec 31, 2010

Type:

Pharmacist-in-Charge (V)

Colleen J. Hayes

License #:

PST.014983-VI - Active

Issued Date:

Sep 23, 1991

Expiration Date:

Dec 31, 2017

Type:

Pharmacist - Voluntary Inactive

Colleen Mae Hayes

License #:

39731 - Expired

Category:

Nursing Support

Issued Date:

Jul 1, 1999

Effective Date:

Jul 11, 2008

Expiration Date:

Jul 1, 2008

Type:

Medication Aide

Colleen Mae Hayes

License #:

39731 - Expired

Category:

Nursing Support

Issued Date:

Mar 17, 1998

Effective Date:

Jun 30, 1999

Type:

Medication Assistant

Lawyers & Attorneys

Colleen Smith Hayes - Lawyer

view source

Licenses:

Connecticut - Active 2002

Colleen Smith Hayes - Lawyer

view source

Licenses:

New York - Currently registered 2003

Education:

Fordham University School of Law

Colleen Hayes - Lawyer

view source

Office:

Goldberg Segalla LLP

Specialties:

Global Insurance Services

ISLN:

924213600

Admitted:

2011

University:

Villanova University, B.A., 2003

Law School:

Villanova University Charles Widger School of Law, J.D., 2011

Us Patents

Use Of Biologically Active Vitamin D Compounds For The Prevention And Treatment Of Inflammatory Bowel Disease
view source
US Patent:

6358939, Mar 19, 2002
Filed:

Dec 21, 1999
Appl. No.:

09/469985
Inventors:

Colleen E. Hayes - Madison WI
Faye E. Nashold - Sun Prairie WI
Assignee:

Northern Lights Pharmaceuticals, LLC - Madison WI
International Classification:

A61K 31593
US Classification:

514167, 552653
Abstract:

Methods of treating inflammatory bowel disease are described, and in particular the prevention and treatment of inflammatory bowel disease in humans as well as other animals. These methods involve the administration of biologically active vitamin D compounds, and therapeutic compositions thereof, so that the symptoms of Inflammatory Bowel Disease are reduced or relieved.

Use Of Biologically Active Vitamin D Compounds For The Prevention And Treatment Of Inflammatory Bowel Disease
view source
US Patent:

6858595, Feb 22, 2005
Filed:

Dec 21, 2001
Appl. No.:

10/036819
Inventors:

Colleen E. Hayes - Madison WI, US
Faye E. Nashold - Sun Prairie WI, US
Assignee:

Wisconsin Alumni Research Association - Madison WI
International Classification:

A61K031/59
C07C401/00
US Classification:

514167, 552653
Abstract:

Methods of treating inflammatory bowel disease are described, and in particular the prevention and treatment of inflammatory bowel disease in humans as well as other animals. These methods involve the administration of biologically active vitamin D compounds, and therapeutic compositions thereof, so that the symptoms of Inflammatory Bowel Disease are reduced or relieved.

Treating Vitamin D Responsive Diseases
view source
US Patent:

6989377, Jan 24, 2006
Filed:

Jun 13, 2002
Appl. No.:

10/170746
Inventors:

Colleen E. Hayes - Madison WI, US
Faye E. Nashold - Sun Prairie WI, US
Assignee:

Wisconsin Alumni Research Foundation - Madison WI
International Classification:

C07C 401/00
A61K 31/59
US Classification:

514167, 552653
Abstract:

The present invention relates to therapeutics for the prevention and treatment of vitamin D responsive diseases in humans, as well as other animals, through the use of biologically active vitamin D compounds in combination with at least one other immunomodulatory compound such as interleukin-10, interleukin-4, or a TNFα inhibitor.

Methods Of Treating Multiple Sclerosis By Administering Pulse Dose Calcitriol
view source
US Patent:

20090221538, Sep 3, 2009
Filed:

Feb 2, 2009
Appl. No.:

12/364364
Inventors:

Colleen E. Hayes - Madison WI, US
Richard Derks - Cottage Grove WI, US
Faye E. Nashold - Sun Prairie WI, US
International Classification:

A61K 31/593
A61P 37/00
US Classification:

514168, 514167
Abstract:

Prophylactic or therapeutic treatment to inhibit the development or progress of multiple sclerosis symptoms is provided by providing intermittently administered elevated doses of calcitriol, sufficiently infrequently to avoid hypercalcemia. Such methods may include maintaining at least about a normal blood level of vitamin Das evidenced by a 25-(OH)Dlevel of at least about 50 nmol/L.

Multiple Sclerosis Treatment
view source
US Patent:

57169462, Feb 10, 1998
Filed:

Feb 13, 1996
Appl. No.:

8/600913
Inventors:

Hector F. DeLuca - Deerfield WI
Colleen E. Hayes - Madison WI
Margherita T. Cantorna - Middleton WI
Assignee:

Wisconsin Alumni Research Foundation - Madison WI
International Classification:

A61K 3159
US Classification:

514167
Abstract:

A method of treating the multiple sclerosis symptoms of a multiple sclerosis patient is disclosed comprising administering to a multiple sclerosis patient an amount of a vitamin D compound effective to reduce symptoms and to enable an observation of a reduction in symptoms.

Treatment Of Arthritic Disease Induced By Infectious Agents
view source
US Patent:

58918655, Apr 6, 1999
Filed:

Oct 4, 1996
Appl. No.:

8/726894
Inventors:

Hector F. DeLuca - Deerfield WI
Margherita T. Cantorna - Middleton WI
Colleen E. Hayes - Madison WI
Assignee:

Wisconsin Alumni Research Foundation - Madison WI
International Classification:

A61K 3159
C07J17500
US Classification:

514167
Abstract:

A method of treating arthritis symptoms induced by an infectious agent of an arthritis patient comprising administering to an arthritis patient an amount of vitamin D compound effective to reduce symptoms and observing a reduction in symptoms is disclosed.

Use Of Vitamin D Compounds To Prevent Transplant Rejection
view source
US Patent:

60718978, Jun 6, 2000
Filed:

Jul 15, 1998
Appl. No.:

9/115958
Inventors:

Hector F. DeLuca - Deerfield WI
Margherita T. Cantorna - Middleton WI
Colleen E. Hayes - Madison WI
Debra A. Hullett - Madison WI
Hans W. Sollinger - Madison WI
Assignee:

Wisconsin Alumni Research Foundation - Madison WI
International Classification:

A61K 3159
US Classification:

514167
Abstract:

A method of moderating transplant rejection in a transplant recipient comprising administering a dose of vitamin D compound effective to prevent transplant rejection is disclosed. Preferably, the recipient's susceptibility to opportunistic infections has not been compromised. Also preferably, the recipient has not suffered bone demineralization.